Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer

Medical Hypotheses

Volumn 68, Issue 3, 2007, Pages 538-540

  Guney, Yildiz ^a   Ozel Turkcu, Ummuhani ^b   Hicsonmez, Ayse ^a   Nalca Andrieu, Meltem ^a   Kurtman, Cengiz ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GHRELIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APPETITE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENERGY EXPENDITURE; HEAD AND NECK CANCER; HUMAN; IMMUNOMODULATION; MALNUTRITION; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INDUCED ANOREXIA; RADIATION INDUCED MUCOSITIS; RADIATION INJURY; WEIGHT REDUCTION;

ANOREXIA; APPETITE; GHRELIN; HEAD AND NECK NEOPLASMS; HUMANS; MUCOSITIS; PEPTIDE HORMONES; RADIOTHERAPY;

EID: 33845958990     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.08.022     Document Type: Article

References (45)

1. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al., Eastern Cooperative Oncology Group. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69 4 (1980) 491-497
2. Laviano A., and Meguid M.M. Nutritional issues in cancer management. Nutrition 12 5 (1996) 358-371
3. Nitenberg G., and Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hemat 34 3 (2000) 137-168
4. Patterson B. Energy balance interventions nutrition and progestins. In: Marty M., and Pecorelli S. (Eds). ESO scientific updates, fatigue and cancer vol. 5 (2001), Elsevier Science B.V., Amsterdam
5. Agrawal A., Chandra D., and Kale R.K. Radiation induced oxidative stress: II studies in liver as a distant organ of tumor bearing mice. Mol Cell Biochem 224 (2001) 9-17
6. Wasserman T.H., and Chapman J.D. Radiation response modulation. In: Perez C.A., Brady L.W., Halperin E.C., and Schmidt-Ullrich R.K. (Eds). Principles and practice of radiation oncology (2004), Lippincott Williams & Wilkins, Philadelphia 663-698
7. Ravasco P., Monteiro Grillo I., Marques Vidal P., and Camilo M.E. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol 15 (2003) 443-450
8. Fearon K., Barber M., and Moses A.G. The cancer cachexia syndrome. Surg Oncol Clin North Am 10 (2001) 109-126
9. Greenspan D. Xerostomia: diagnosis and management. Oncology (Williston Park) 10 Suppl. 3 (1996) 7-11
10. Whitmyer C.C., Waskowski J.C., and Iffland H.A. Radiotherapy and oral sequelae: preventive and management protocols. J Dent Hyg 71 1 (1997) 23-29 Review. Erratum in: J Dent Hyg 1997;71(3):96
11. Epstein J.B., Emerton S., Kolbinson D.A., Le N.D., Phillips N., Stevenson-Moore P., et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21 1 (1999) 1-11
12. Hunter A.M. Nutrition management of patients with neoplastic disease of the head and neck treated with radiation therapy. Nutr Clin Pract 11 (1996) 157-169
13. Deitel M., and To T.B. Major intestinal complications of radiotherapy. Management and nutrition. Arch Surg 122 12 (1987) 1421-1424
14. Grosvenor M., Bulcavage L., and Chlebowski R.T. Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63 2 (1989) 304-330
15. Sonti G., Ilyin S.E., and Plata-Salaman C.R. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 270 6 Pt 2 (1996) R1394-R1402
16. Opara E.I., Laviano A., and Meguid M.M. Correlation between food intake and cerebrospinal fluid interleukin 1-αin anorectic tumor-bearing rats. Nutrition 11 Suppl. 5 (1995) 678-679
17. Laviano A., Gleason J.R., Meguid M.M., Yang Z.J., Cangiano C., and Rossi Fanelli F. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Invest Med 48 1 (2000) 40-48
18. Martenson J.A., Hyland G., Moertel C.G., et al. Olsalazine is contraindicated during pelvic radiation therapy: results of double-blind, randomized trial. Int J Radiat Oncol Biol Phys 35 (1996) 299-303
19. Michalowski A.S. On radiation damage to normal tissues and treatment. Acta Oncol 33 (1994) 139-157
20. Peters L.J. Radiation therapy tolerance limits: for one or for all? Janeway lecture. Cancer 77 (1996) 2379-2385
21. Westermann W., Schobl R., Rieber R., and Frank K.H. Th2 cells as effectors in post-irradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol 75 (1999) 629-638
22. Sonis S.T., Elting L.S., Keefe D., Peterson D.E., Schubert M., Hauer-Jensen M., et al., Mucositis study section of the multinational association for supportive care in cancer; international society for oral oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 Suppl. 9 (2004) 1995-2025
23. Goncalves Dias M.C., de Fatima Nunes Marucci M., Nadalin W., and Waitzberg D.L. Nutritional intervention improves the caloric and proteic ingestion of head and neck cancer patients under radiotherapy. Nutr Hosp 20 5 (2005) 320-325
24. Matthews T.W., Lampe H.B., and Dragosz K. Nutritional status in head and neck cancer patients. J Otolaryngol 24 (1995) 87-91
25. Colasanto J.M., Prasad P., Nash M.A., Decker R.H., and Wilson L.D. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) 19 3 (2005) 371-379 discussion 380-2, 387
26. Jamieson N.B., Brown D.J., Michael Wallace A., and McMillan D.C. Adiponectin and the systemic inflammatory response in weight-losing patients with nonsmall cell lung cancer. Cytokine 27 (2004) 90-92
27. Wallace A.M., Kelly A., Sattar N., McArdle C.S., and McMillan D.C. Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutr Cancer 44 (2002) 157-160
28. Nayel H., el-Ghoneimy E., and el Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutrition 8 (1992) 13-18
29. Pajak T.F., Laramore G.E., Marcial V.A., Fazekas J.T., Cooper J., Rubin P., et al. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 20 1 (1991) 13-20
30. Lee W.R., Berkey B., Marcial V., et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 42 (1998) 1069-1075
31. Lopez M.J., Robinson P., Madden T., and Highbarger T. Nutritional support and prognosis in patients with head and neck cancer. J Surg Oncol 55 (1994) 33-36
32. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
33. Van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (2004) 426-457
34. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 6806 (2000) 908-913
35. Eisenstein J., and Greenberg A. Ghrelin: update 2003. Nutr Rev 61 3 (2003) 101-104
36. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 6817 (2001) 194-198
37. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocr Metab 86 12 (2001) 5992
38. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 5277 (1996) 974-977
39. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Bioph Res Co 279 3 (2000) 909-913
40. Gualillo O., Lago F., Gomez-Reino J., Casanueva F.F., and Dieguez C. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. Febs Lett 552 (2003) 105-109 24
41. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocr Metab 85 12 (2000) 4908-4911
42. Adeghate E., and Ponery A.S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 14 7 (2002) 555-560
43. Broglio F., Benso A., Gottero C., Prodam F., Grottoli S., Tassone F., et al. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57 2 (2002) 265-271
44. Groschl M., Knerr I., Topf H.G., Schmid P., Rascher W., and Rauh M. Endocrine responses to the oral ingestion of a physiological dose of essential amino acids in humans. J Endocrinol 179 2 (2003) 237-244
45. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114 1 (2004) 57-66